US Patent 8389488 Antidotes to antisense compounds
Patent 8389488 was granted and assigned to Ionis Pharmaceuticals on March, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 27 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+207 characters)
Article
Patent abstract
The present invention relates to antisense antidote compounds and uses thereof. Such antidote compounds reduce the magnitude and/or duration of the antisense activity of an antisense compound.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Andrew M. Siwkowski0
Brett P. Monia0
Hong Zhang0
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08389488 Antidotes to antisense compounds US Patent 8389488 Antidotes to antisense compounds
Infobox
Patent Number
083894880
Patent Number
83894880
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
083894880
Date of Patent
March 5, 2013
0Patent Application Number
127409740
Date Filed
November 5, 2008
0Patent Primary Examiner
Edits on 16 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08389488 Antidotes to antisense compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08389488
Date of patent
March 5, 2013
Patent application number
12740974
Date Filed
November 5, 2008
Patent primary examiner
Find more entities like US Patent 8389488 Antidotes to antisense compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
